| CYSB2500095 | 赖脯胰岛素注射液 | insulin lispro | Injection | Biological Products | Supplementary Application | 2025-05-09 | | Lilly Suzhou Pharmaceutical Co Ltd | | | view |
| CXSL2500272 | 注射用LY4101174 | LY4101174 | Lyophilized | Biological Products(1) | New Drug Application | 2025-04-08 | | Lilly Suzhou Pharmaceutical Co Ltd | | | view |
| CXSL2500049 | 注射用LY4052031 | LY-4052031 | | Biological Products(1) | New Drug Application | 2025-01-16 | | Lilly Suzhou Pharmaceutical Co Ltd | | | view |
| CXSL2400415 | LY3540378注射液 | | Injection | Biological Products(1) | New Drug Application | 2024-06-27 | | Lilly Suzhou Pharmaceutical Co Ltd | | | view |
| CYSB2200275 | 精蛋白锌重组赖脯胰岛素混合注射液（25R） | | Injection | Biological Products | Supplementary Application | 2022-12-13 | | Lilly Suzhou Pharmaceutical Co Ltd | | | view |
| CYSB2200013 | 赖脯胰岛素注射液 | insulin lispro | Injection | Biological Products | Supplementary Application | 2022-01-13 | | Lilly Suzhou Pharmaceutical Co Ltd | | | view |
| CYSB2101244 | 精蛋白人胰岛素混合注射液（30R） | human insulin;isophane protamine human insulin | Injection | Biological Products | Supplementary Application | 2021-10-28 | | Lilly Suzhou Pharmaceutical Co Ltd | | | view |
| CYSB2101210 | 人胰岛素注射液 | human insulin | Injection | Biological Products | Supplementary Application | 2021-10-09 | | Lilly Suzhou Pharmaceutical Co Ltd | | | view |
| JXHL2100115 | LOXO-305片 | pirtobrutinib | Tablet | Chemical Drugs(1) | Import Drug Application | 2021-04-08 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Loxo Oncology Inc | In Review | 2021-04-07 | view |
| JXHL2100113 | LOXO-305片 | pirtobrutinib | Tablet | Chemical Drugs(1) | Import Drug Application | 2021-04-08 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Loxo Oncology Inc | In Review | 2021-04-07 | view |
| JXHL2100114 | LOXO-305片 | pirtobrutinib | Tablet | Chemical Drugs(1) | Import Drug Application | 2021-04-08 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Loxo Oncology Inc | In Review | 2021-04-07 | view |
| JXSL2100045 | LY3471851注射液 | | Injection | Biological Products(1) | Import Drug Application | 2021-03-31 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company | In Review | 2021-03-30 | view |
| JXSB2100023 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2021-03-20 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company | In Review | 2021-03-19 | view |
| JXHL2100093 | LOXO-305 | pirtobrutinib | Active ingredient | Chemical Drugs(1) | Import Drug Application | 2021-03-20 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Loxo Oncology Inc | In Review | 2021-03-19 | view |
| JXHL2100092 | LOXO-305 | pirtobrutinib | Active ingredient | Chemical Drugs(1) | Import Drug Application | 2021-03-20 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Loxo Oncology Inc | In Review | 2021-03-19 | view |
| JXSB2100025 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2021-03-20 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company | In Review | 2021-03-19 | view |
| JXHL2100091 | LOXO-305 | pirtobrutinib | Active ingredient | Chemical Drugs(1) | Import Drug Application | 2021-03-20 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Loxo Oncology Inc | In Review | 2021-03-19 | view |
| JXSB2100024 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2021-03-20 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company | In Review | 2021-03-19 | view |
| JXHL2100090 | LOXO-305 | pirtobrutinib | Active ingredient | Chemical Drugs(1) | Import Drug Application | 2021-03-20 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Loxo Oncology Inc | In Review | 2021-03-19 | view |
| JXHL2100069 | 注射用LY3437943 | retatrutide | Lyophilized | Chemical Drugs(1) | Import Drug Application | 2021-03-04 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company | In Review | 2021-03-04 | view |
